Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 8/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.37 |
| ▸ | RXRA | P19793 | 6/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7749510 | 1.00 | KDM4E (0.37) | KDM4ESMN1; SMN2TDP1L3MBTL1NR1H2 | |
| SCHEMBL7749531 | 0.92 | NR1H2 (0.38) | KDM4ESMN1; SMN2NR1H2NR1H3RXRA | |
| SCHEMBL7749529 | 0.92 | NR1H2 (0.38) | KDM4ESMN1; SMN2NR1H2NR1H3RXRA | |
| SCHEMBL7749562 | 0.91 | NR1H2 (0.38) | SMN1; SMN2NR1H2NR1H3RXRAHIF1A | |
| SCHEMBL7749565 | 0.91 | NR1H2 (0.38) | SMN1; SMN2NR1H2NR1H3RXRAHIF1A | |
| SCHEMBL7754457 | 0.91 | NR1H2 (0.39) | KDM4ESMN1; SMN2NR1H2NR1H3RXRA | |
| SCHEMBL7754455 | 0.91 | NR1H2 (0.39) | KDM4ESMN1; SMN2NR1H2NR1H3RXRA | |
| SCHEMBL7755672 | 0.89 | NR1H2 (0.36) | L3MBTL1NR1H2NR1H3RXRARAB9A | |
| SCHEMBL7755669 | 0.89 | NR1H2 (0.36) | L3MBTL1NR1H2NR1H3RXRARAB9A | |
| SCHEMBL7753650 | 0.87 | SMN1; SMN2 (0.43) | KDM4ESMN1; SMN2TDP1L3MBTL1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | CRAMP MICHAEL COLIN (GB) | 2001-10-11 | — | — | US | disclosed |
| WO-2001047863-A2 | NEW HERBICIDAL COMPOSITIONS | AVENTIS CROPSCIENCE SA (FR) | 2001-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | DDT, CYP1B1, CYP4X1 | KDM4E 200/4885SMN1; SMN2 3729/4885TDP1 1180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.